FIELD: biotechnology; immunology.
SUBSTANCE: invention relates to biotechnology and immunology, in particular to antibodies or their antigen-binding fragments that specifically bind to interferon beta (IFNβ). Such antibodies or their antigen-binding fragments are applicable for various therapeutic or diagnostic purposes, namely, to reduce the activity of IFNβ in an individual, to treat rheumatoid diseases, to treat systemic lupus erythematosus.
EFFECT: obtaining anti-interferon beta antibodies for treating various diseases.
27 cl, 20 dwg, 18 tbl, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DOSING REGIMEN FOR TFPI ANTAGONISTS | 2019 |
|
RU2780590C1 |
| ANTIGEN-BINDING PROTEINS AGAINST GITR AND METHODS OF THEIR USE | 2017 |
|
RU2795625C2 |
| ANTIBODIES B7-H4 AND METHODS FOR THEIR APPLICATION | 2019 |
|
RU2809243C2 |
| ANTIGEN-BINDING PROTEINS AGAINST TIGIT AND THEIR APPLICATION METHODS | 2018 |
|
RU2776714C2 |
| ANTIBODIES AND ANTIBODY-DRUG CONJUGATES SPECIFIC TO CD123 AND THEIR USE | 2018 |
|
RU2789150C2 |
| MONOVALENT ANTIBODIES TO PROPERDIN AND FRAGMENTS OF ANTIBODIES | 2018 |
|
RU2790103C2 |
| METHODS FOR DETECTING FOLATE RECEPTOR 1 IN PATIENT SAMPLE | 2018 |
|
RU2759410C2 |
| ANTIBODIES AGAINST ANG-2 CONTAINING ONLY HEAVY CHAIN | 2016 |
|
RU2749674C2 |
| ILT7 BINDING MOLECULES AND THEIR APPLICATION METHODS | 2017 |
|
RU2756109C2 |
| ANTIBODIES TO PAC1 AND THEIR APPLICATION OPTIONS | 2019 |
|
RU2781553C2 |
